DrugScope Statement: Project Prevention Is “Exploitative, Ethically Dubious And Morally Questionable”, UK

DrugScope Statement: Project Prevention Is “Exploitative, Ethically Dubious And Morally Questionable”, UK
In response to debate in today’s media over the work of controversial American charity Project Prevention, DrugScope, the national membership organisation for the drug sector and a leading centre of expertise on drug issues, has issued the following statement. According to BBC reporting, the US charity is establishing a UK operational arm which is currently offering £200 to any drug user in …
Read more on Medical News Today

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR
New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.
Read more on News-Medical-Net